Clearly explainedEvidence-based guidance

The essentials

What is vitiligo?

Vitiligo is an acquired pigmentary disorder. In affected areas, pigment-producing melanocytes are lost or no longer work adequately, creating distinctly pale or white patches.

Diagram explaining vitiligo in the skin
Illustration supporting the information presented on this page.

In brief

Key points

  • Vitiligo is not contagious
  • It can begin at any age
  • Autoimmune mechanisms are common
  • Its course varies between people
  • Dermatological diagnosis matters
01

What happens in the skin?

Melanocytes make melanin, the pigment that contributes to skin colour. In vitiligo, functioning melanocytes decrease in defined areas and the skin loses colour.

Current evidence points to several interacting processes, including an immune response directed against melanocytes, genetic susceptibility, oxidative stress and local factors.

02

Which forms are recognised?

Non-segmental vitiligo is the most common form and often affects both sides of the body. Segmental vitiligo usually follows a more localised, one-sided pattern. Mixed forms are less common.

  • Non-segmental: often bilateral or symmetrical
  • Segmental: usually unilateral and regional
  • Mixed: features of both forms
  • Extent and activity are assessed separately
03

Why seek medical advice?

Several conditions can cause pale patches. Examination helps confirm the diagnosis, assess activity and discuss suitable goals.

Vitiligo is not life-threatening, but depigmented skin is more sensitive to UV exposure and the visible change can have a substantial emotional impact.

Editorial basis

Editorial basis: AWMF S2k guideline on the diagnosis and treatment of vitiligo, register 013-093, version 2.0 dated 27 July 2026, valid until June 2031. Sources reviewed on 2 September 2026.

Commercial links are limited to approved IDEALDERM product information.